Our Science – Arons Website
Evgeny Arons, Ph.D.
Selected Publications |
 |
| 1)
Arons E, Roth L, Sapolsky J, Suntum T, Stetler-Stevenson M, Kreitman RJ. Evidence of canonical somatic hypermutation in hairy cell leukemia. Blood. 117: 4844-51, 2011. [Journal] |
|
| 2)
Kreitman RJ, Arons E, Stetler-Stevenson M, Miller KB. Response of hairy cell leukemia to bendamustine. Leukemia & lymphoma. 2011. [Journal] |
|
| 3)
Arons E, Suntum T, Stetler-Stevenson M, Kreitman RJ. VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood. 114: 4687-95, 2009. [Journal] |
|
| 4)
Arons E, Suntum T, Margulies I, Yuan C, Stetler-Stevenson M, Kreitman RJ. PRAME expression in hairy cell leukemia. Leuk. Res. 32: 1400-6, 2008. [Journal] |
|
| 5)
Arons E, Suntum T, Sunshine J, Stetler-Stevenson M, Kreitman RJ. Immunoglobulin light chain repertoire in hairy cell leukemia. Leuk. Res. 31: 1231-6, 2007. [Journal] |
|
| 6)
Arons E, Sorbara L, Raffeld M, Stetler-Stevenson M, Steinberg SM, Liewehr DJ, Pastan I, Kreitman RJ. Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy. Cancer Immunol. Immunother. 55: 1100-10, 2006. [Journal] |
|
| 7)
Arons E, Margulies I, Sorbara L, Raffeld M, Stetler-Stevenson M, Pastan I, Kreitman RJ. Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction. Clin. Cancer Res. 12: 2804-11, 2006. [Journal] |
|
| 8)
Arons E, Sunshine J, Suntum T, Kreitman RJ. Somatic hypermutation and VH gene usage in hairy cell leukaemia. Br. J. Haematol. 133: 504-12, 2006. [Journal] |
|
| 9)
Arons E, Kunin V, Schechter C, Ehrlich R. Organization and functional analysis of the mouse transporter associated with antigen processing 2 promoter. J. Immunol. 166: 3942-51, 2001. [Journal] |
|
| 10)
Arons E, Zusman T, Ran M. The in vivo enhancement of IL-1alpha receptor expression on polyoma virus transformed tumor derived cells. Int. J. Oncol. 12: 1379-83, 1998. [Journal] |
|
| 11)
Zusman T, Lisansky E, Arons E, Anavi R, Bonnerot C, Sautes C, Fridman WH, Witz IP, Ran M. Contribution of the intracellular domain of murine Fc-gamma receptor type IIB1 to its tumor-enhancing potential. Int. J. Cancer. 68: 219-27, 1996. [Journal] |
|
| Click Here to View Collapsed Bibliography. |
This page was last updated on 5/18/2011.
